Vemlidy 25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FATZT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,042
Award facts
- Contract value 100% obligated
- $8,042.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,042.37 to DMS Pharmaceutical Group Inc. for the supply of Vemlidy 25 mg tablets (30-count unit doses). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected on a firm fixed-price basis with an ultimate completion date of October 28, 2025. The award carries no set-aside designation, indicating the company competed unrestricted in the federal procurement process. The place of performance is identified as Conshohocken, Pennsylvania.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, with a completion date of December 31, 2036, and authorizes DLA to issue firm fixed-price delivery orders for pharmaceuticals and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across diverse therapeutic categories and product lines demonstrates its capability as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FATZT?
SPE2DB26FATZT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FATZT worth?
The government has obligated $8,042 on SPE2DB26FATZT.
Is contract SPE2DB26FATZT an order under another contract?
Yes. SPE2DB26FATZT is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZT competed?
The extent of competition for SPE2DB26FATZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award